Xianghong Jasmine Zhou
Directeur Général chez EarlyDiagnostics, Inc.
Profil
Xianghong Jasmine Zhou is the founder of EarlyDiagnostics, Inc., a company she founded in 2017.
She currently holds the titles of President, Co-CEO, and Chief Financial Officer at EarlyDiagnostics, Inc.
Postes actifs de Xianghong Jasmine Zhou
Sociétés | Poste | Début |
---|---|---|
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | Directeur Général | 01/01/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | Technology Services |